BOVINE MASTITIS MARKET ANALYSIS

Bovine Mastitis Market, by Type (Clinical Mastitis and Sub-clinical Mastitis), by Product (Antibiotics, Vaccines, Pain Killers, and Others), by Route of Administration (Intra-mammary and Systemic), by Therapy (Lactating Period, Dry Period (Antibiotics, and Teat Sealants)), by End User (Veterinary Centers, Hospital, Clinics, and Others), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031

Published In : Mar 2024
Code : CMI4947
Pages :204
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

Recent Developments

In September 2022, Boehringer Ingelheim, a renowned global player in animal health, announced that the Clinical and Laboratory Standards Institute (CLSI) had endorsed enhanced interpretation criteria for Ubrolexin susceptibility testing. The Federation of Veterinarians of Europe (FVE) promotes the practice of conducting susceptibility testing whenever possible to determine the optimal antimicrobial treatment for a particular illness. The capacity to assess the susceptibility of a mastitis-specific antibiotic combination empowers veterinarians to select the optimal treatment, thereby, aiding in resistance prevention.

Increasing product launches for animal healthcare is expected to boost the market growth during the forecast period.

Cows are more susceptible to mastitis during dry off due to the environmental and physiological changes they go through. Because keratin plug growth changes throughout the dry period, a cow's natural barrier against new intramammary infections, pathogen risk is higher. When dry cows are exposed to high levels of environmental infections, National Mastitis Council's Recommended Mastitis Control Program recommends using a teat sealant. For instance, in February 2020 Merck & Co. Inc. announced the launch of Shut Out, a sterile, antibiotic-free barrier and a novel teat sealant solution. The product is intended to be used prior to dry off, in order to help avoid intramammary infections.